Mira Pharmaceuticals (MIRA) Free Cash Flow (2022 - 2025)

Mira Pharmaceuticals has reported Free Cash Flow for 4 years, with the latest figure at -$1.2 million in Q4 2025.

• Quarterly Free Cash Flow rose 33.52% year-over-year to -$1.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$4.7 million (up 15.48% YoY) and the FY2025 annual result came in at -$4.7 million, up 15.48% from the prior year.
• Free Cash Flow slipped to -$1.2 million in Q4 2025 per MIRA's latest filing, from -$1.1 million in the prior quarter.
• Over five years, Free Cash Flow peaked at -$660813.0 in Q2 2023 and troughed at -$1.8 million in Q3 2024.
• A 4-year average of -$1.2 million and a median of -$1.1 million in 2023 frame the typical range for Free Cash Flow.
• The sharpest annual moves came in 2024 and 2025: Free Cash Flow plunged 74.4% in 2024, then surged 40.29% in 2025.
• Over 4 years, Free Cash Flow stood at -$975436.0 in 2022, then slipped by 6.11% to -$1.0 million in 2023, then slumped by 74.4% to -$1.8 million in 2024, then surged by 33.52% to -$1.2 million in 2025.
• According to Business Quant data, Free Cash Flow over the past three periods registered -$1.2 million, -$1.1 million, and -$769973.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.